Daniel Lamontagne

Author PubWeight™ 12.24‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Contribution of endogenous endothelin in the enhanced coronary constriction in DOCA-salt hypertensive rats. J Hypertens 2003 1.41
2 Comparison of the cardiovascular protection by omapatrilat and lisinopril treatments in DOCA-salt hypertension. J Hypertens 2003 1.40
3 Antioxidative properties of acetylsalicylic Acid on vascular tissues from normotensive and spontaneously hypertensive rats. Circulation 2002 0.94
4 Contribution of endocannabinoids in the endothelial protection afforded by ischemic preconditioning in the isolated rat heart. Life Sci 2003 0.94
5 Endocannabinoids protect the rat isolated heart against ischaemia. Br J Pharmacol 2003 0.93
6 Endothelial CB1-receptors limit infarct size through NO formation in rat isolated hearts. Life Sci 2007 0.89
7 Endocannabinoids are implicated in the infarct size-reducing effect conferred by heat stress preconditioning in isolated rat hearts. Cardiovasc Res 2002 0.89
8 Cardiac and peripheral actions of growth hormone and its releasing peptides: relevance for the treatment of cardiomyopathies. Cardiovasc Res 2005 0.85
9 Signaling pathways involved in the cardioprotective effects of cannabinoids. J Pharmacol Sci 2006 0.84
10 Role of nitric oxide and protein kinase C in the tachyphylaxis to vasopressin in rat aortic rings. Life Sci 2005 0.83
11 Chronic antioxidant treatment improves sympathetic functions and beta-adrenergic pathway in the spontaneously hypertensive rats. J Hypertens 2003 0.82
12 Rescue of amitriptyline-intoxicated hearts with nanosized vesicles. Cardiovasc Res 2007 0.80
13 A study of the mediators involved in the protection induced by exogenous kinins in the isolated rat heart. Int Immunopharmacol 2003 0.78
14 The cardioprotective effect of dual metallopeptidase inhibition: respective roles of endogenous kinins and natriuretic peptides. Can J Physiol Pharmacol 2005 0.75
15 Bradykinin metabolism in rat hearts with left-ventricular hypertrophy following myocardial infarction. Can J Physiol Pharmacol 2003 0.75